Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Fig. 3

REG exerts potent anti-angiogenic effects in orthotopic CT26 tumors. a Tumor vascularization analyzed by DCE-MRI. Longitudinal effects on vascularization are shown by relative amplitude changes versus baseline (day 4). b Representative images. Left panel: T1-weighted MR images with overlayed amplitude parameter maps derived from DCE-MRI analyses (scale bar indicates arbitrary units); right panel: IF staining for CD31 (green), VEGFR2 (red) and nuclei (DAPI; blue). Yellow staining indicates overlapping signal for CD31 and VEGFR2. Scale bar: 100 µm. c Effects on tumor vasculature analyzed by immunofluorescence (IF) on frozen tumor sections for CD31 and VEGFR2 and quantified: mean values ± SD (n = 5–7) and individual values (dots). Statistical significance (§day 7; #day 11; * day 14): */§/#p < 0.05; **/§§/##p < 0.01; ***/§§§/###p < 0.001; ****/§§§§/####p < 0.0001

Back to article page